MedPath

Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Other: Ultra Conservative ICD Programming
Other: Traditional ICD Programming
Registration Number
NCT01977703
Lead Sponsor
Vanderbilt University Medical Center
Brief Summary

We propose to study a strategy empirically applied for the past 6 months at a high volume LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative device programming strategy to maximize battery longevity, avoid inappropriate implantable cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in overall shock burden, and potentially avoid unnecessary device generator changes prior to transplant. Avoiding CIED (cardiac implantable electronic device) change out device procedures prior to transplant is desirable.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Ultra Conservative ICD ProgrammingUltra Conservative ICD ProgrammingICD will be set to ultra conservative settings post LVAD implant.
Traditional ICD ProgrammingTraditional ICD ProgrammingICD will be set to pre-LVAD settings post LVAD implant.
Primary Outcome Measures
NameTimeMethod
Time to first ICD shock following LVAD implantWithin 12 months following LVAD implant
Secondary Outcome Measures
NameTimeMethod
Frequency of ICD generator change prior to definitive therapyWithin 12 months following LVAD implant

Number of patients requiring ICD generator change

Hospitalization frequency for decompensated congestive heart failureWithin 12 months following LVAD implant

Number of hospitalizations

Cardiac implantable electronic device (CIED) battery voltage/estimated longevity changesWithin 12 months following LVAD implant

Battery voltage and battery life measured in days

Frequency of anti-tachycardia pacing (ATP) therapy administration for appropriate or inappropriate arrhythmia detectionWithin 12 months following LVAD implant

Number of ATP occurrences

Frequency of arrhythmic syncopeWithin 12 months following LVAD implant

Number of syncope occurrences

Determine survival to heart transplantation following LVAD implantWithin 12 months following LVAD implant

Number of patients, post LVAD implant, to receive heart transplant and number of survival days post implant

Trial Locations

Locations (1)

Vanderbilt University

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath